Irene Katzan, M.D., M.S.
| Appointed: |
2001 |
| Gender: |
Female |
| Languages: |
English |
Cerebrovascular Center
Neurology
Professional Highlights
- Michael Pessin Stroke Leadership Award, American Academy of Neurology (2006)
- Distinguished Achievement Award, American Heart Association, Ohio Valley Affiliate (2004)
- Director, Primary Stroke Center, Cleveland Clinic
- Director, Knowledge Program, Neurological Institute
Education & Fellowships
| Medical School: | The Ohio State University College of Medicine and Public Health, Columbus, OH |
|
| Internship: | Riverside Methodist Hospital, Preliminary Medicine, Columbus, OH |
| Residency: | Cleveland Clinic, Neurology, Cleveland, OH |
| Fellowship: | Cleveland Clinic, Cerebrovascular Disease, Cleveland, OH |
| Other Education: | (Graduate) Case Western Reserve University, Cleveland, OH |
| Other Education: | (Undergraduate) Kenyon College, Gambier, OH |
Certifications
Vascular Neurology
Neurology
Specialty Interests
Cerebrovascular disease, stroke outcomes, neurovascular ultrasound, secondary stroke prevention.
Awards & Honors
- Pacesetter Award for Excellence in Stroke Research and Treatment (2006), American Stroke Association, Northeastern Ohio Branch
- Michael Pessin Stroke Leadership Award, American Academy of Neurology (2006)
- Distinguished Achievement Award, American Heart Association, Ohio Valley Affiliate (2004)
- Best Doctors in America (2003-2004, 2005-2006, 2007,2008)
- Award of Excellence, American Heart Association, Northeastern Ohio Branch (2003)
- I.H. Page Center for Health Outcomes Research Award (2001)
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/4/2008, Dr. Katzan has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Katzan receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Genentech, Inc.
- Novartis Institutes for BioMedical Research, Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
